Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Association between handgrip strength and quality of life among adults with asthma: Findings from a nationally representative Korean population

  • Joo Hyeok Hong,

    Roles Data curation, Formal analysis, Writing – original draft

    Affiliation Graduate School of Nursing and Health Professions, Chung-Ang University, Seoul, Korea

  • Moon Seong Baek,

    Roles Conceptualization, Investigation, Methodology, Writing – review & editing

    Affiliation Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea

  • Bomi Park

    Roles Conceptualization, Project administration, Supervision, Validation, Writing – review & editing

    bpark@cau.ac.kr

    Affiliation Department of Preventive Medicine, College of Medicine, Chung-Ang University, Seoul, Republic of Korea

Abstract

Asthma is a prevalent chronic disease worldwide, and individuals with asthma often experience reduced quality of life (QOL) due to symptoms such as dyspnea and impaired physical function. Given the vulnerability of this population, identifying strategies to maintain or improve QOL is essential. Asthma-related physical inactivity and muscle weakness may increase the risk of sarcopenia, which can further deteriorate QOL. This study aimed to examine the association between handgrip strength and health-related QOL in Korean adults with asthma. We used data from the Korea National Health and Nutrition Examination Survey conducted between 2014 and 2019. A total of 867 adults aged ≥19 years who reported a physician diagnosis of asthma and completed handgrip strength and EuroQol 5-Dimension (EQ-5D) assessments were included. Participants were categorized into high- and low-handgrip-strength groups based on sex-specific thresholds (28.9 kg for men and 16.8 kg for women). The EQ-5D index was used to classify patients into low-, middle-, and high-QOL groups. Multinomial logistic regression analyses were conducted to evaluate the association between handgrip strength and QOL, adjusting for age, sex, household income, education, smoking status, high-risk alcohol use, resistance exercise, body mass index, hypertension, diabetes, arthritis, and depression. Participants with higher handgrip strength were more likely to be in the high-QOL group than those with lower handgrip strength (adjusted OR = 2.25; 95% CI: 1.22–4.16). In the subgroup analyses, the association was significant in women (adjusted OR = 2.89; 95% CI: 1.32–6.29), but not in men. A significant association was also observed in participants with as-needed medication use, but not in those with daily medication use. Higher handgrip strength was associated with better QOL in adults with asthma, particularly among women and those with less severe disease. Interventions aimed at improving muscle strength may contribute to enhanced QOL in this population.

1. Introduction

Asthma is one of the most common non-communicable chronic diseases, affecting over 260 million people worldwide as of 2019, and is responsible for more than 450,000 deaths annually [1]. In South Korea, the prevalence of asthma increased from approximately 1.6% in 2002 to 2.2% in 2015, with the mortality rate rising from 16.2 to 28 per 100,000 population [2]. Furthermore, recent studies have indicated a gradual increase in asthma prevalence among young adults in their 20s [3].

Asthma imposes substantial economic and social burdens because of medication costs, hospitalization, and productivity loss. For instance, in the United States, the economic burden of asthma increased from USD 56 billion in 2007 [4] to approximately USD 82 billion in 2013 [5]. In South Korea, the estimated health care cost of asthma is approximately USD 646 million [6]. Thus, asthma represents a significant public health issue not only for individuals, but also for society as a whole [7,8].

People with asthma may experience reduced physical activity owing to limitations in daily living and physical functioning, which can lead to muscle weakness and overall physical decline [9]. Prior studies have suggested that patients with chronic respiratory symptoms often find it difficult to engage in muscle-strengthening activities, which further limits their mobility and exacerbates muscle loss [10,11]. Consequently, patients with asthma may be at an increased risk of sarcopenia because of long-term inactivity [12]. Additionally, the long-term use of low-dose inhaled corticosteroids, a core element of asthma management according to the Global Initiative for Asthma (GINA) guidelines [13], has been reported to promote muscle protein breakdown and suppress synthesis, leading to muscle atrophy and reduced exercise capacity [14,15]. These effects may be particularly pronounced in patients with severe asthma undergoing prolonged treatment [16].

Asthma symptoms such as dyspnea, coughing, and chest tightness can limit participation in everyday activities, potentially resulting in impairments across occupational, academic, and recreational domains [17]. Accordingly, asthma has been associated with reduced quality of life (QOL). Inadequately controlled asthma or severe symptoms may also contribute to psychological distress, including anxiety and depression, further lowering QOL [1822].

Previous research has shown that individuals with low handgrip strength are more likely to experience limited physical activity, difficulty with daily functioning, and psychological distress, all of which are associated with poorer QOL [2326]. Therefore, improving muscle strength, as reflected by handgrip strength, may represent a potential intervention strategy for enhancing QOL in patients with asthma.

However, few studies have examined the epidemiological association between handgrip strength and QOL, specifically among individuals with asthma. Therefore, this study aimed to investigate the association between handgrip strength and health-related QOL (EuroQol 5-Dimension [EQ-5D]) in Korean adults with asthma and assess whether handgrip strength could serve as a potential target for interventions aimed at improving QOL in this population.

2. Materials and methods

2.1. Study population and data source

This study utilized data from the sixth (2014–2015), seventh (2016–2018), and eighth (2019) cycles of the Korea National Health and Nutrition Examination Survey (KNHANES), a nationwide cross-sectional survey conducted by the Korea Disease Control and Prevention Agency. KNHANES employs a stratified, multistage probability sampling design to collect nationally representative health data from the non-institutionalized Korean population. The survey includes a health interview, health examination, and nutrition survey. As handgrip strength was not assessed during the COVID-19 pandemic in 2020 owing to safety restrictions, only data from 2014 to 2019 were included in this study.

Adults aged ≥ 19 years who reported having ever been diagnosed with asthma by a physician and completed assessments of handgrip strength and QOL (EQ-5D) were eligible. Asthma severity was classified based on self-reported medication use in the past year with reference to the 2021 GINA guidelines. Participants were categorized into two medication-use patterns: as-needed medication and daily medication, based on their self-reported frequency of asthma medication use during the past year [27].

Participants were excluded if they were under 19 years of age, had a history of cancer (to minimize bias from serious comorbid conditions), or had missing data for any of the key variables, including EQ-5D, body mass index (BMI), hypertension, diabetes, household income, smoking status, education level, high-risk alcohol use, or resistance exercise.

The study protocol was approved by the Institutional Review Board of Chung-Ang University (IRB No. 1041078-20241018-HR-295). The requirement for informed consent was waived because the analysis was conducted using de-identified, publicly available data. The data were accessed for research purposes between November 15, 2024, and December 31, 2024, and the authors did not have access to any information that could identify individual participants during or after data collection.

2.2. Handgrip strength

In this study, handgrip strength was used as an indirect marker (proxy) of sarcopenia, as data on muscle mass and physical performance tests were not available in the KNHANES. Handgrip strength was measured using a digital dynamometer (T.K.K 5401, Japan) in accordance with the KNHANES protocols. Each participant performed three trials per hand, and the highest value among the six measurements was used for the analysis.

Handgrip strength was categorized as low (<28.9 kg for men and <16.8 kg for women) or high, based on Korean population-specific reference data derived from a nationally representative sample [28]. These cutoffs were chosen to maintain comparability with other Korean studies. Although they differ slightly from the Asian Working Group for Sarcopenia (AWGS) recommendations (<28 kg for men and <18 kg for women), the Korean reference values were considered more appropriate given population-specific anthropometric characteristics and measurement protocols.

In addition, handgrip strength was analyzed as a continuous variable (per 1-kg and per 1-SD increase). Linearity of the association was assessed by comparing linear and restricted cubic spline (3-knot) models using the Akaike Information Criterion (AIC). A ΔAIC < 2 indicated no meaningful improvement in model fit by the spline, supporting a linear specification.

2.3. Quality of life (EQ-5D)

Health-related QOL was assessed using the EQ-5D questionnaire, a standardized instrument that measures five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression [29,30]. Each item is rated on a three-point scale (1 = no problems, 2 = some problems, 3 = extreme problems), and the responses are converted to a single index value [31]. Based on the distribution of the index scores, the participants were categorized into three QOL groups:

  1. High QOL: EQ-5D index = 1.0
  2. Middle QOL: EQ-5D index < 1.0 and ≥ median value among those not in the high QOL group
  3. Low QOL: EQ-5D index < median value

2.4. Covariates

Covariates were selected based on previous literature linking them to handgrip strength and/or QOL [3239]. These included age, sex, household income (categorized into tertiles: low, middle, and high), education level (middle school or less vs. high school or more), smoking status (current smoker vs. former/never smoker), high-risk alcohol use (defined as ≥7 drinks per occasion for men or ≥5 drinks per occasion for women, at least twice per week), resistance exercise (≥2 days per week vs. < 2 days), BMI (categorized as normal <23, overweight 23–24.9, and obese ≥25), and physician-diagnosed hypertension, diabetes, arthritis, and depression.

2.5. Statistical analysis

Descriptive statistics were used to summarize the demographic and clinical characteristics of the study population. Participants with missing values for any variable included in the model were excluded from the respective analyses, without statistical imputation. Categorical variables are presented as unweighted frequencies and weighted percentages, and continuous variables are presented as medians and interquartile ranges (IQRs). Chi-squared tests were used to examine the associations between categorical variables, and Wilcoxon rank-sum tests were used to compare continuous variables.

Multinomial logistic regression analyses were conducted to examine the association between handgrip strength and EQ-5D QOL. Analyses were stratified by sex and asthma medication-use pattern. Because KNHANES uses a complex sampling design, all analyses incorporated survey weights, strata, and primary sampling units using the SURVEY procedures in SAS version 9.4 (SAS Institute Inc., Cary, NC, USA). The results are presented as odds ratios (ORs) and 95% confidence intervals (CIs), with statistical significance defined as a two-sided p-value < 0.05.

3. Results

Among the 42,853 participants in the 2014–2019 KNHANES, 1,260 individuals reported a physician diagnosis of asthma. After excluding those under 19 years of age, those with a history of cancer (n = 43), and individuals with missing values in key variables (n = 73), a total of 867 participants were included in the final analysis (Fig 1).

thumbnail
Fig 1. Flow diagram of participant selection from the KNHANES.

https://doi.org/10.1371/journal.pone.0338197.g001

Table 1 summarizes the demographic characteristics of the participants by sex and asthma medication-use pattern. Of the 867 participants, 341 (39.3%) were men and 526 (60.7%) were women. A total of 678 (78.2%) patients reported as-needed medication use, and 189 (21.8%) reported daily medication use. Based on the handgrip strength criteria, 729 (84.1%) participants were classified in the high-handgrip group and 138 (15.9%) in the low-handgrip group. A higher proportion of men (86.8%) belonged to the high-handgrip-strength group compared with women (82.3%; p = 0.072). Additionally, the proportion of participants with high handgrip strength was greater among those with as-needed medication (86.4%) than among those with daily medication (75.7%) (p < 0.001). A total of 474 (54.7%) participants were classified into the high QOL group, and 160 (18.4%) into the low QOL group. Among men, 64.5% were in the high group and 13.2% in the low group; among women, 48.3% were in the high group and 21.9% in the low group. In participants with as-needed medication, 58.4% were classified in the high group and 16.1% in the low group, whereas in those with daily medication, 41.3% were in the high group and 27.0% in the low group.

thumbnail
Table 1. Demographic and clinical characteristics of study participants by sex and asthma medication-use pattern.

https://doi.org/10.1371/journal.pone.0338197.t001

Table 2 shows the association between handgrip strength and EQ-5D. After adjusting for covariates, participants in the high-handgrip-strength group had higher odds of belonging to the high-QOL group than those in the low-handgrip-strength group (adjusted OR = 2.25; 95% CI: 1.22–4.16). The odds of being in the middle-QOL group were also higher (adjusted OR = 1.68; 95% CI: 0.92–3.04), although the result was not statistically significant.

thumbnail
Table 2. Multinomial logistic regression of categorical handgrip strength and EQ-5D.

https://doi.org/10.1371/journal.pone.0338197.t002

Table 3 presents the results of the stratified analysis by sex. Among men, high handgrip strength was associated with increased odds of being in the middle-QOL group (OR = 1.59; 95% CI: 0.48–5.28) and the high-QOL group (OR = 1.75; 95% CI: 0.56–5.49); however, these associations were not statistically significant. In contrast, among women, those in the high-handgrip-strength group had significantly higher odds of being in the high-QOL group (OR = 2.89; 95% CI: 1.32–6.29). The odds for the middle-QOL group were also elevated (OR = 1.93; 95% CI: 0.96–3.86), though they were not statistically significant.

thumbnail
Table 3. Multinomial logistic regression of categorical handgrip strength and EQ-5D by sex.

https://doi.org/10.1371/journal.pone.0338197.t003

Table 4 shows the results stratified by asthma medication-use pattern. Among the as-needed medication group, those with high handgrip strength had significantly higher odds of being in the high-QOL group (OR = 2.36; 95% CI: 1.12–4.99) and moderately higher odds for the middle-QOL group (OR = 1.92; 95% CI: 0.92–3.98), though the latter did not reach statistical significance. Among the daily medication group, the associations between handgrip strength and QOL were not statistically significant (OR = 1.83; 95% CI: 0.58–5.79).

thumbnail
Table 4. Multinomial logistic regression of categorical handgrip strength and EQ-5D by asthma medication-use pattern.

https://doi.org/10.1371/journal.pone.0338197.t004

Table 5 presents the associations between continuous handgrip strength and EQ-5D. A significant positive association was observed among women, whereas no significant association was found in other subgroups. Comparison between restricted cubic spline and linear models yielded ΔAIC < 2, indicating no evidence of nonlinearity. The direction and pattern of the associations were consistent with those observed in the categorical analyses, showing a higher QOL with greater handgrip strength. However, the effect sizes were smaller in the continuous models, as they represent the change per unit increase rather than contrasts between high and low categories.

thumbnail
Table 5. Multinomial logistic regression of continuous handgrip strength (per kg and per SD) and EQ-5D.

https://doi.org/10.1371/journal.pone.0338197.t005

4. Discussion

This study investigated the association between handgrip strength and health-related quality of life (EQ-5D) in Korean adults with asthma. Individuals with higher handgrip strength were significantly more likely to report better quality of life, particularly women and those using as-needed asthma medication. These findings suggest that maintaining or improving muscular strength may play an important role in enhancing the quality of life among patients with asthma.

When handgrip strength was analyzed as a continuous variable, the direction of the association with EQ-5D was consistent with that observed in the categorical analyses, showing a higher QOL with increasing grip strength. Although the magnitude of the association was smaller and statistical significance was observed only among women, the overall pattern remained linear and positive.

Handgrip strength was used in this study as a proxy for sarcopenia. Previous studies have established strong correlations between handgrip strength and muscle mass and function, making it a reliable marker of physical capability [4042]. Prior studies have shown that reduced handgrip strength is associated with lower QOL in specific populations, such as older adults [43] and patients with arthritis [24], chronic obstructive pulmonary disease (COPD) [44], and osteoporosis [45]. However, to the best of our knowledge, no previous study has examined this relationship in patients with asthma. Our findings expand on the literature by showing that lower handgrip strength is also associated with lower QOL in adults with asthma. While earlier studies have reported associations between low handgrip strength and increased mortality in respiratory diseases [46] and severe airflow limitation [47], our findings demonstrated a novel association between handgrip strength and QOL in this population.

Stratified analyses revealed that the association between handgrip strength and QOL was significant only in women. This may be because of sex-specific differences in muscle mass and the prevalence of sarcopenia. Research has shown that sarcopenia is more prevalent in women than in men as age increases [48], possibly because of hormonal factors. Testosterone levels in men rise sharply after puberty, leading to greater muscle mass and strength than in women of the same age and training level [49,50]. Men also tend to have a larger cross-sectional area of muscle and slower rates of muscle loss with age [32]. In contrast, postmenopausal women experience a decline in estrogen levels, which contributes to reduced muscle mass and joint pain in nearly 77% of women [33]. Studies have also reported that women with low handgrip strength are significantly more likely to experience mobility issues (OR = 2.12) and limitations in daily activities (OR = 2.04) [34].

Moreover, women may experience greater psychological benefits from physical improvement than men. Increased muscle strength in women has been linked to reduced stress and improved emotional stability [35,36], and women are generally more prone to depression and anxiety, which may further influence their QOL [37].

Interestingly, the association between handgrip strength and QOL was significant only in participants with as-needed medication use. This finding is consistent with those of previous studies on patients with respiratory disease, where those with milder disease severity showed stronger associations between physical function and QOL [38]. One possible explanation is that patients with severe chronic diseases, such as advanced COPD, may experience limited QOL improvements despite treatment, as disease progression often outweighs the benefits of physical improvement [39]. Although the exact mechanisms remain unclear, these findings suggest that physical interventions may be more effective in improving the QOL of patients with less severe asthma.

Several biological mechanisms may underlie the reduced muscle strength observed in adults with asthma–chronic systemic inflammation (IL-6, TNF-α) [51,52], intermittent hypoxia with ventilatory limitation during exacerbations [53], physical deconditioning driven by fear of dyspnea [53], and steroid-induced myopathy with prolonged corticosteroid exposure [54,55]. These processes can reduce skeletal-muscle function and exercise capacity, leading to mobility limitations, greater fatigue, and lower performance of daily activities, which are reflected in EQ-5D domains; this pathway provides biological plausibility for the observed association between lower handgrip strength and lower quality of life in asthma.

Overall, this study has several important public health and clinical implications. First, asthma is associated with substantial reductions in QOL owing to both physical and psychological burdens. Previous studies have shown that QOL decreases as asthma severity increases [56,57], and even with adequate treatment, many patients with asthma report lower QOL than patients without asthma [58] . Therefore, improving the QOL of patients with asthma remains a crucial goal. Our findings indicate that interventions to improve muscle strength, particularly handgrip strength, may be a promising strategy to support better health outcomes, especially for women and individuals with mild asthma. Rehabilitation programs or physical activity interventions designed to enhance muscular strength can be integrated into routine asthma care.

To our knowledge, this is one of the few studies to explore the relationship between handgrip strength and QOL in patients with asthma using nationally representative data. Stratified analysis by sex and asthma severity provided additional insights into the subgroups that may benefit most from strength-based interventions. These findings may support the development of tailored strategies to manage asthma and enhance patient-centered outcomes.

However, this study has some limitations. First, its cross-sectional design precluded the determination of a causal relationship between handgrip strength and QOL. Second, although multiple covariates were adjusted for, the potential for residual confounding variables remains because some were unmeasured. Third, because the study population was limited to Korean adults, the generalizability of the findings to other ethnic or cultural groups may be limited. Future longitudinal and interventional studies are needed to confirm whether improving handgrip strength leads to improvements in QOL and to expand on these findings to broader populations. Fourth, EQ-5D was analyzed as a categorical variable (low, intermediate, and high) rather than as a continuous score. Although this approach was chosen to address the marked right-skew and ceiling effect commonly observed in EQ-5D data, it may have resulted in a loss of statistical power and information compared with treating EQ-5D as a continuous variable. Finally, the distinction between as-needed medication and daily medication was based on the self-reported frequency of use. While practical, this measure does not fully reflect the GINA-defined multidimensional severity and may involve misclassification due to differences in adherence.

5. Conclusion

This study demonstrated a significant association between handgrip strength and QOL (EQ-5D) in Korean adults with asthma. Individuals with higher handgrip strength were more likely to report a better QOL, particularly women and those with mild asthma severity. These findings highlight the potential value of incorporating muscle-strengthening interventions into asthma management strategies to improve patient well-being. Strengthening programs targeting specific subgroups, such as women and those with less severe disease, may be especially effective. Future longitudinal and intervention-based research is needed to further explore causal relationships and assess the impact of muscular strength improvements on QOL in diverse asthma populations.

References

  1. 1. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22. pmid:33069326
  2. 2. Lee E, Kim A, Ye Y-M, Choi S-E, Park H-S. Increasing prevalence and mortality of asthma with age in Korea, 2002–2015: a nationwide, population-based study. Allergy Asthma Immunol Res. 2020;12(3):467.
  3. 3. Jeon DS, Kim MJ, Lee JS, Lee SW, Oh Y-M. Trend of asthma prevalence and risk factors in the 20s age band in South Korea. J Thorac Dis. 2023;15(5):2450–7. pmid:37324106
  4. 4. Barnett SBL, Nurmagambetov TA. Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol. 2011;127(1):145–52.
  5. 5. Nurmagambetov T, Kuwahara R, Garbe P. The economic burden of asthma in the United States, 2008–2013. Ann Am Thorac Soc. 2018;15(3):348–56.
  6. 6. Lee E-W, Kim H-S, Kim W, Nam J-Y, Park J-H. Socioeconomic burden of disease due to asthma in South Korea. Asia Pac J Public Health. 2020;32(4):188–93.
  7. 7. Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract. 2017;3:1. pmid:28078100
  8. 8. Håkansson KEJ, Løkke A, Ibsen R, Hilberg O, Backer V, Ulrik CS. Beyond direct costs: individual and societal financial burden of asthma in young adults in a Danish nationwide study. BMJ Open Respir Res. 2023;10(1):e001437. pmid:37156597
  9. 9. Nyenhuis SM, Kahwash B, Cooke A, Gregory KL, Greiwe J, Nanda A. Recommendations for physical activity in asthma: a work group report of the AAAAI Sports, Exercise, and Fitness Committee. J Allergy Clin Immunol Pract. 2022;10(2):433–43. pmid:34844909
  10. 10. Zampogna E, Zappa M, Spanevello A, Visca D. Pulmonary rehabilitation and asthma. Front Pharmacol. 2020;11:542. pmid:32435190
  11. 11. Osadnik CR, Gleeson C, McDonald VM, Holland AE. Pulmonary rehabilitation versus usual care for adults with asthma. Cochrane Database Syst Rev. 2022;8(8):CD013485. pmid:35993916
  12. 12. Hurst C, Robinson SM, Witham MD, Dodds RM, Granic A, Buckland C, et al. Resistance exercise as a treatment for sarcopenia: prescription and delivery. Age Ageing. 2022;51(2):afac003. pmid:35150587
  13. 13. Papi A, Blasi F, Canonica GW, Morandi L, Richeldi L, Rossi A. Treatment strategies for asthma: reshaping the concept of asthma management. Allergy Asthma Clin Immunol. 2020;16(1).
  14. 14. Kourakis S, Timpani CA, Campelj DG, Hafner P, Gueven N, Fischer D, et al. Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: can we do better? Orphanet J Rare Dis. 2021;16(1):117. pmid:33663533
  15. 15. Mundell L, Lindemann R, Douglas J. Monitoring long-term oral corticosteroids. BMJ Open Qual. 2017;6(2):e000209.
  16. 16. Ramos E, de Oliveira LVF, Silva AB, Costa IP, Corrêa JCF, Costa D, et al. Peripheral muscle strength and functional capacity in patients with moderate to severe asthma. Multidiscip Respir Med. 2015;10(1):3. pmid:25973197
  17. 17. Kharaba Z, Feghali E, El Husseini F, Sacre H, Abou Selwan C, Saadeh S, et al. An Assessment of quality of life in patients with asthma through physical, emotional, social, and occupational aspects. a cross-sectional study. Front Public Health. 2022;10:883784. pmid:36117601
  18. 18. Adams RJ. Psychological factors and asthma quality of life: a population based study. Thorax. 2004;59(11):930–5.
  19. 19. Gonzalez-Barcala F-J, de la Fuente-Cid R, Tafalla M, Nuevo J, Caamaño-Isorna F. Factors associated with health-related quality of life in adults with asthma. A cross-sectional study. Multidiscip Respir Med. 2012;7(1).
  20. 20. McDonald VM, Hiles SA, Jones KA, Clark VL, Yorke J. Health-related quality of life burden in severe asthma. Med J Aust. 2018;209(S2):S28–33. pmid:30453870
  21. 21. Stubbs MA, Clark VL, Gibson PG, Yorke J, McDonald VM. Associations of symptoms of anxiety and depression with health-status, asthma control, dyspnoea, dysfunction breathing and obesity in people with severe asthma. Respir Res. 2022;23(1):341. pmid:36510255
  22. 22. Pfeffer PE, Brown T, Chaudhuri R, Faruqi S, Gore R, Heaney LG, et al. Impact of comorbidities on EQ-5D quality-of-life index in severe asthma. J Allergy Clin Immunol: Glob. 2024;3(3):100286.
  23. 23. Kim H, Yoo S, Kim H, Park SG, Son M. Cancer survivors with low hand grip strength have decreased quality of life compared with healthy controls: the Korea National Health and Nutrition Examination Survey 2014-2017. Korean J Fam Med. 2021;42(3):204–11. pmid:34038988
  24. 24. Chang S-Y, Han B-D, Han K-D, Park H-J, Kang S. Relation between handgrip strength and quality of life in patients with arthritis in Korea: The Korea National Health and Nutrition Examination Survey, 2015-2018. Medicina (Kaunas). 2022;58(2):172. pmid:35208496
  25. 25. Kitamura M, Izawa KP, Ishihara K, Brubaker PH, Matsuda H, Okamura S, et al. Differences in health-related quality of life in older people with and without sarcopenia covered by long-term care insurance. Eur J Investig Health Psychol Educ. 2022;12(6):536–48. pmid:35735461
  26. 26. Yang J, Guo G, Yang F, Li C, Wang H, Yang W, et al. A sex-oriented analysis concerning skeletal muscle quantity and quality and associations to quality of life in hospitalized patients with cirrhosis. Health Qual Life Outcomes. 2024;22(1).
  27. 27. Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, et al. Global initiative for asthma strategy 2021. executive summary and rationale for key changes. Arch Bronconeumol. 2022;58(1):35–51. pmid:35245179
  28. 28. Kim CR, Jeon Y-J, Kim MC, Jeong T, Koo WR. Reference values for hand grip strength in the South Korean population. PLoS One. 2018;13(4):e0195485. pmid:29624617
  29. 29. Brooks R, Boye KS, Slaap B. EQ-5D: a plea for accurate nomenclature. J Patient Rep Outcomes. 2020;4(1).
  30. 30. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–43. pmid:11491192
  31. 31. Lee Y-K, Nam H-S, Chuang L-H, Kim K-Y, Yang H-K, Kwon I-S, et al. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value Health. 2009;12(8):1187–93. pmid:19659703
  32. 32. Schorr M, Dichtel LE, Gerweck AV, Valera RD, Torriani M, Miller KK, et al. Sex differences in body composition and association with cardiometabolic risk. Biol Sex Differ. 2018;9(1):28. pmid:29950175
  33. 33. Chidi-Ogbolu N, Baar K. Effect of estrogen on musculoskeletal performance and injury risk. Front Physiol. 2019;9:1834. pmid:30697162
  34. 34. Kang SY, Lim J, Park HS. Relationship between low handgrip strength and quality of life in Korean men and women. Qual Life Res. 2018;27(10):2571–80. pmid:29922911
  35. 35. Zhang J, Xu L, Li J, Sun L, Qin W, Ding G, et al. Gender differences in the association between body mass index and health-related quality of life among adults:a cross-sectional study in Shandong, China. BMC Public Health. 2019;19(1):1021. pmid:31366336
  36. 36. Verde Z, Giaquinta A, Sainz CM, Ondina MD, Araque AF. Bone mineral metabolism status, quality of life, and muscle strength in older people. Nutrients. 2019;11(11):2748. pmid:31726780
  37. 37. Castellano-Guerrero AM, Guerrero R, Ruiz-Aranda D, Perea S, Pumar A, Relimpio F, et al. Gender differences in quality of life in adults with long-standing type 1 diabetes mellitus. Diabetol Metab Syndr. 2020;12:64. pmid:32695233
  38. 38. Jung HI, Gu K-M, Park SY, Baek MS, Kim WY, Choi J-C, et al. Correlation of handgrip strength with quality of life-adjusted pulmonary function in adults. PLoS One. 2024;19(3):e0300295. pmid:38466692
  39. 39. Tsai S-H, Hung J-Y, Su P-F, Hsu C-H, Yu C-H, Liao X-M, et al. Chronic obstructive pulmonary disease trajectory: severe exacerbations and dynamic change in health-related quality of life. BMJ Open Respir Res. 2024;11(1):e002037. pmid:38387996
  40. 40. Sousa-Santos AR, Amaral TF. Differences in handgrip strength protocols to identify sarcopenia and frailty - a systematic review. BMC Geriatr. 2017;17(1):238. pmid:29037155
  41. 41. Lee SH, Gong HS. Measurement and interpretation of handgrip strength for research on sarcopenia and osteoporosis. J Bone Metab. 2020;27(2):85–96. pmid:32572369
  42. 42. Sayer AA, Cruz-Jentoft A. Sarcopenia definition, diagnosis and treatment: consensus is growing. Age Ageing. 2022;51(10):afac220. pmid:36273495
  43. 43. Halaweh H. Correlation between health-related quality of life and hand grip strength among older adults. Exp Aging Res. 2020;46(2):178–91. pmid:31928183
  44. 44. Jeong M, Kang HK, Song P, Park HK, Jung H, Lee S-S, et al. Hand grip strength in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017;12:2385–90. pmid:28848339
  45. 45. Park HJ, Han B, Chang S-Y, Kang SH, Lee DW, Kang S. Hand grip strength, osteoporosis, and quality of life in middle-aged and older adults. Medicina (Kaunas). 2023;59(12):2148. pmid:38138251
  46. 46. Mey R, Calatayud J, Casaña J, Torres-Castro R, Cuenca-Martínez F, Suso-Martí L, et al. Handgrip strength and respiratory disease mortality: Longitudinal analyses from SHARE. Pulmonology. 2024;30(5):445–51. pmid:36274049
  47. 47. Kim S, Yoon HK, Rhee CK, Jung H-W, Lee H, Jo YS. Hand grip strength and likelihood of moderate-to-severe airflow limitation in the general population. Int J Chron Obstruct Pulmon Dis. 2022;17:1237–45. pmid:35642183
  48. 48. Bianchi L, Abete P, Bellelli G, Bo M, Cherubini A, Corica F, et al. Prevalence and clinical correlates of sarcopenia, identified according to the EWGSOP definition and diagnostic algorithm, in hospitalized older people: the GLISTEN study. J Gerontol A Biol Sci Med Sci. 2017;72(11):1575–81. pmid:28329345
  49. 49. Ben Mansour G, Kacem A, Ishak M, Grélot L, Ftaiti F. The effect of body composition on strength and power in male and female students. BMC Sports Sci Med Rehabil. 2021;13(1):150. pmid:34839825
  50. 50. Hunter SK, S Angadi S, Bhargava A, Harper J, Hirschberg AL, D Levine B, et al. The biological basis of sex differences in athletic performance: consensus statement for the American College of Sports Medicine. Med Sci Sports Exerc. 2023;55(12):2328–60. pmid:37772882
  51. 51. Rossi GP. A comprehensive review of the clinical aspects of primary aldosteronism. Nat Rev Endocrinol. 2011;7(8):485–95. pmid:21610687
  52. 52. McKenzie DK, Gosselink R, Midorikawa K. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease and asthma: mechanisms and clinical implications. Clin Sci (Lond). 2014;126:575–84.
  53. 53. Tan CY, Hagen T. Destabilization of CDC6 upon DNA damage is dependent on neddylation but independent of Cullin E3 ligases. Int J Biochem Cell Biol. 2013;45(7):1489–98. pmid:23597704
  54. 54. Guan W-J, Zhong N-S. Letter from China. Respirology. 2020;25(6):657–8. pmid:32270532
  55. 55. Severinsen MC, Pedersen BK. Muscle–organ crosstalk: The emerging roles of myokines. Endocr Rev. 2020;41:594–610.
  56. 56. Oh B-C, Lee J-E, Nam JH, Hong J-Y, Kwon S-H, Lee E-K. Health-related quality of life in adult patients with asthma according to asthma control and severity: a systematic review and meta-analysis. Front Pharmacol. 2022;13:908837. pmid:36479200
  57. 57. Song HJ, Blake KV, Wilson DL, Winterstein AG, Park H. Health-related quality of life and health utilities of mild, moderate, and severe asthma: evidence from the medical expenditure panel survey. J Asthma Allergy. 2021;14:929–41. pmid:34349523
  58. 58. Hossny E, Caraballo L, Casale T, El-Gamal Y, Rosenwasser L. Severe asthma and quality of life. World Allergy Organ J. 2017;10(1):28. pmid:28855973